Pfiz­er raids Roche ex­ec­u­tive com­mit­tee for new drug de­vel­op­ment chief — and Schwan plucks his re­place­ment from the board

Pfiz­er has found its new chief of drug de­vel­op­ment, and they’ve dis­patched a raid­ing par­ty to Basel to pluck him off the ex­ec­u­tive com­mit­tee at Roche.

William Pao, who took over as head of pRED af­ter John Reed ex­it­ed to take the R&D chief post at Sanofi in 2018, is head­ed to the ex­ec­u­tive com­mit­tee at Pfiz­er now, where he’ll re­port to Al­bert Bourla in New York. And he has a big re­mit that in­cludes “in­flam­ma­tion and im­munol­o­gy, in­ter­nal med­i­cine, hos­pi­tal, on­col­o­gy and rare dis­ease, as well as reg­u­la­to­ry af­fairs in sup­port of Pfiz­er’s R&D pipeline and port­fo­lio of mar­ket­ed ther­a­pies.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER